Healthcare -
Biotechnology - NASDAQ - US
$ 0.492
0 %
$ 121 M
Market Cap
-1.37
P/E
SGMO - CASH FROM OPERATIONS
Cash from Operations SGMO - Sangamo Therapeutics, Inc.
-67.1 M
LAST VALUE
45.21%
2 YEAR CAGR
14.20%
5 YEAR CAGR
-28.03%
10 YEAR CAGR